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Introduction
Measles is a highly contagious disease that is still a 
major cause of childhood death and severe disability 
[1,2]. Although an inexpensive and efficacious vaccine 
has been available since the 1960s, measles caused 
approximately 140,000 deaths globally in 2010, with the 
highest burden in Sub-Saharan Africa [2]. In the World 
Health Organization (WHO) European region, a sig-
nificant decline in reported measles cases was seen in 
the last 2 decades, with cases decreasing from 304,184 
in 1991, to 67,759 in 2001 and 8617 cases in 2009 [3]. 
Despite this substantial reduction, the initial goal of 
eliminating measles in the WHO European region by 
Measles among migrants in the European Union and the European 
Economic Area
GEMMA A. WIllIAMS1, SAbrINA bAccI2, rEbEccA SHADWIck1, 
TAAvI TIllMANN3, bErND rEcHEl4, TEyMur NOOrI2, JONATHAN E. Suk2, 
ANNA ODONE4,5, JONATHAN D. INGlEby6, PHIlIPA MlADOvSky1 
& MArTIN MckEE4
1LSE Health, London School of Economics and Political Science (LSE), London, UK, 2European Centre for Disease 
Prevention and Control (ECDC), Stockholm, Sweden, 3ECOHOST, London School of Hygiene and Tropical Medicine, 
London, UK, 4European Observatory on Health Systems and Policies, London School of Hygiene and Tropical Medicine, 
London, UK, 5Department of Global Health and Social Medicine, Harvard School of Public Health, Harvard University, 
Boston, MA, USA,6School of Medicine, University of Parma, Parma, Italy, and 7Centre for Social Science and Global 
Health, University of Amsterdam, Amsterdam, the Netherlands
Abstract
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2010 (defined as the absence of endemic measles or 
rubella cases in a defined geographical area for a period 
of at least 12 months in the presence of a well-perform-
ing surveillance system [4]), was not met, and the 
number of measles cases in recent years has started to 
increase [3]. In 2012, there were 33,602 measles cases 
reported by the countries of the WHO European 
region, with 10,271 cases reported by European 
union (Eu)/European Economic Area (EEA) mem-
ber states [3]. Measles was targeted for elimination by 
2015 [5], but this goal will not be achieved. Progress 
towards measles elimination has been hindered, as 
some children are either not immunized on time or are 
never immunized (the recommended age for immuni-
zation varies from 6–15 months, with a second dose 
required, as 2–5% of children over 12 months of age do 
not respond to the first dose). Sub-optimal coverage 
rates often occur in at-risk groups, such as the roma, 
Irish travellers and orthodox religious communities; 
this results in clusters of unvaccinated individuals that 
reduce overall population coverage below the 95% 
minimum that is needed for eradication [6] and con-
tributes to dissemination of the disease to other sec-
tions of the population.
A further group that is thought to be at increased 
risk of measles due to insufficient vaccination cover-
age is migrants. Although migrants are often compar-
atively healthy, a phenomenon known as the ‘healthy 
migrant effect’ [7], some studies suggest that certain 
groups of migrants in Europe are more vulnerable to 
infectious diseases, such as measles, than the majority 
population [8–10]; however, current information on 
the extent to which migrants in the Eu/EEA are 
affected by measles is limited, due to a lack of data.
First, comparisons of migrant health across Europe 
are challenging, due to varied definitions of who con-
stitutes a migrant. Definitions and classifications are 
determined by national legislative, administrative and 
policy factors [11]; therefore, migrants may be classi-
fied by their country of birth, nationality, residency or 
duration of stay [12,13]. Secondly, the quality and 
type of surveillance data collected still vary greatly 
between countries. In Europe, measles is a notifiable 
disease in all 53 member states of the WHO European 
region; surveillance data for Eu/EEA member states 
are collected by the European centre for Disease 
Prevention and control (EcDc), shared with the 
WHO European region Office and then published 
routinely on the EcDc website [3,14]. However, 
although efforts have been made in recent years to 
harmonize national surveillance data collected on 
migrant-specific variables, such as ‘country of birth’ 
or whether a case is ‘imported or endemic’, this infor-
mation is inadequately reported for measles in the 
majority of member states.
understanding and meeting the health needs of 
migrants affected by infectious diseases is becoming 
increasingly important, in part due to increasing 
migration flow to and within Europe [15]. In 1990, 
6.9% of the total Eu population was foreign-born, a 
figure that has increased to 9.7% of the total popula-
tion in 2011 [16]. There were an estimated 48.9 mil-
lion foreign-born residents in the 27 Eu member 
states in 2011, with 32.4 million having been born 
outside the Eu and 16.5 million having been born in 
a different Eu country [16].
The increasing diversity of European populations 
is inevitably creating new challenges for health sys-
tems, which need to adapt in order to accommodate 
disparate health needs [17,18]. If the goal of elimi-
nating measles is to be met, it is necessary to target 
the groups at risk of remaining unvaccinated with 
specific health information and disease prevention 
campaigns [19]. At present, the lack of data makes 
it difficult to determine if migrant populations are 
at higher risk of contracting measles. In light of 
these gaps in evidence, this paper aims to provide an 
overview of the burden of measles in migrants in the 
Eu/EEA and to give an assessment of the quality, 
completeness and comparability of data. Evidence 
was collected through a comprehensive literature 
review, expert opinion from infectious disease spe-
cialists and a survey of national key informants.
Methods
Comprehensive literature review
A comprehensive literature review was conducted to 
critically appraise and summarize the available evi-
dence on both the burden of measles and measles, 
mumps and rubella (MMr) vaccination coverage 
rates in migrant populations in the Eu/EEA. We 
identified the studies to be included in the compre-
hensive literature review by searching electronic 
databases and relevant websites, scanning reference 
lists of papers and by asking infectious disease experts 
to identify key publications. We conducted the litera-
ture search between July and September 2012, and 
updated it in April 2015, using three electronic data-
bases and 18 websites of key organizations. The data-
bases and the websites searched for the literature 
review were:
 • Databases (last date searched: 07 April 2015): 
PubMed/Medline, Web of Science and cochrane 
library.
 • key websites (last date searched: 07 April 2015): 
central European Forum for Migration and 
Population research (Poland); center for Health 
and Migration (Austria); Danish research centre 
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for Migration, Ethnicity and Health (MESu); 
EcDc; Eugate; European research centre on 
Migration and Ethnic relations (ErcOMEr); 
Eu-level consultation on Migration Health; 
Health Protection Agency (HPA); Global Forum 
on Migration and Development (GFMD); Global 
migration group, International Organization for 
Migration (IOM); Migrant and Ethnic Health 
Observatory, National Health Service (NHS); 
united Nations Population Fund (uNFPA); the 
European health Association uPHA; the WHO; 
and the World Health Organization, regional 
Office for Europe (WHO-EurO).
Our database search strategy was built using a 
combination of keywords related to measles, migrants 
and the study setting (Eu/EEA):
 • Measles;
 • AND Migration, immigration, emigration, 
migrant, immigrant, emigrant, foreign-born, for-
eign born, foreigner, asylum seeker, refugee, 
irregular, citizen, citizenship and nationality;
 • AND Austria, belgium, bulgaria, cyprus, czech 
republic, Denmark, Estonia, Finland, France, 
Germany, Greece, Hungary, Iceland, Ireland, Italy, 
latvia, liechtenstein, lithuania, luxembourg, 
Malta, Netherlands, Norway, Poland, Portugal, 
romania, Slovakia, Slovenia, Spain, Sweden, uk, 
Great britain, England, Wales, Scotland, Eu, Eu/
EEA and Europe.
Articles were included if they were descriptive and 
analytic observational studies, experimental studies, 
reviews, systematic reviews and meta-analyses; were 
published in English; and included data on measles 
in the Eu/EEA. Data from non-Eu/EEA publica-
tions were considered for inclusion to provide back-
ground information only.
Eligibility assessment for inclusion was performed 
independently by two reviewers, initially by screening 
titles and abstracts, followed by a full-text review to 
determine final eligibility. Disagreements between 
reviewers were resolved by discussion. Data relevant to 
the study questions were retrieved, with high priority 
given to recent nationally-representative studies and 
large population-based studies. No minimum sample 
size was selected, but small hospital-based studies were 
only included if no other data were available and they 
reported their limitations in terms of generalizability.
Expert meeting
In October 2012, the EcDc and the Portuguese 
National Health Institute in lisbon co-hosted an 
expert meeting on infectious diseases and migration. 
The meeting enabled experts to present feedback on 
the survey to their member states, and allowed mem-
ber states to share examples of best practice on sur-
veillance, prevention and control targeted toward 
migrant populations in various infectious disease 
areas. We include evidence presented at this meeting 
to provide additional information on the patterns 
and reasons for measles outbreaks in individual 
member states.
Survey of EU/EEA member states
A survey of key informants in Eu/EEA member 
states was conducted to collect migrant-relevant 
measles data not reported to the EcDc’s ‘The 
European Surveillance System’ (TESSy) database. 
In May 2012 through July 2012 we developed ques-
tionnaires for the survey, which contained open-
ended questions on the occurrence of measles 
among migrants, how migrants are defined for the 
purpose of measles surveillance and if any specific 
data are available. A table was also constructed to 
collect data on the incidence and mortality rates for 
2007–2010. The questionnaires were sent out elec-
tronically to the EcDc disease focal points in all 
Eu/EEA member states in July through August 
2012, requesting a response within 4 weeks. We also 
considered using data from the TESSy database, but 
the only potentially relevant variables were ‘importa-
tion status’ and ‘probable country of infection’, with 
no information collected on ‘country of birth’, sig-
nificantly limiting any conclusions that might be 
drawn on measles in migrants. Therefore, this data 
source was not included.
Results
Comprehensive literature review
The literature search identified 195 papers for evalu-
ation. After screening abstracts and titles, 37 articles 
were selected for full-text screening. Of these articles, 
20 were found to meet the inclusion criteria and were 
included in the final review. The literature review 
revealed very few papers that studied measles among 
migrants in Europe; those that mentioned migrants 
frequently conflated them with indigenous religious 
or ethnic minorities. Many studies did differentiate 
‘imported’ from other cases, but did not ascertain 
whether the imported cases were in the indigenous 
population whom had travelled abroad and returned 
infected. Thus, these studies did not provide mean-
ingful information on the burden of disease among 
migrant populations.
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One of the largest studies using surveillance data 
illustrates these difficulties. It used national data 
from 32 European countries from 2006–2007, cover-
ing a total of 12,132 reported cases of measles, of 
which 210 (1.7% ) were reported as ‘imported’, 117 
(56%) of which were from another European coun-
try, and 43 (20%) of which were from Asia [20] . The 
study provided little information specifically on 
migrant populations; it merely noted the presence of 
measles outbreaks in 2005–2009 among certain 
indigenous populations, such as the roma and Sinti, 
Travellers, anthroposophic (a particular philosophi-
cal-spiritual community) and ultra-orthodox Jewish 
communities [20] .
There were similar problems with the case studies 
of measles outbreaks, many of which discuss ethnic 
minorities, but do not specify whether these include 
recent migrants or not. Thus, a report on an Irish 
measles outbreak in 2009–2010 mentioned that two-
thirds of the cases were in unvaccinated subjects, and 
that the majority of them were from the Traveller 
community, or “others from Eastern Europe” [21]. 
In France, an outbreak in 2008–2010 was reported 
to have particularly affected roma and “gens du voy-
age” (nomadic populations) [22]. yet, it was again 
unclear whether these were migrant populations, 
non-migrant itinerant groups, or both. Another epi-
demiological study on a 2008 measles outbreak in 
Germany reported that a new strain of measles virus 
(D4-Hamburg) was imported from london to 
Hamburg and then to bulgaria, with the spread of 
the virus being predominantly associated with travel 
by the roma individuals [23]. Additional informa-
tion was provided in a report on a Greek measles out-
break in 2010, which highlighted the roma 
communities as bearing a disproportionately high 
case load, noting that they came from both Greece 
and bulgaria [24]. Similarly, two measles outbreaks 
in lazio, Italy in 2006 and 2007 were noted as having 
disproportionately affected the roma/Sinti commu-
nity, with index cases identified as unvaccinated 
roma/Sinti children of romanian nationality[25]. 
One study that did identify cases in migrants reported 
that 8 of 10 measles cases in an outbreak in Oslo in 
2011 were from the Somali immigrant community, 
with two cases in Norwegian children [26].
Immunization is key to the elimination of measles, 
yet outbreaks and fatalities continue in Europe 
because vaccination rates remain below the recom-
mended coverage level of at least 95%, leaving pock-
ets of vulnerable groups unprotected [27]. In some 
Eu/EEA countries, these outbreaks have been linked 
to migrant populations with low or sub-optimum cov-
erage [28]; however, as with incidence data, data on 
immunization rates in migrant populations is limited. 
In many Eu/EEA countries, these data are not rou-
tinely collected [28]. Moreover, migrants may not be 
registered with a national health system. It is also nec-
essary to place any data in a national context, with far 
lower immunization rates typically in Western than in 
Eastern Europe [29]; however, data on the determi-
nants of non-immunization matter: most of the 
reported measles infections in Europe during 2005–
2009 were in unvaccinated or previously uninfected 
individuals, with recent outbreaks concentrated in 
remaining pockets of susceptible individuals [20,30].
There are a few studies from individual countries 
on immunization rates in those persons explicitly 
identified as migrants by country of birth, often find-
ing that they are less likely to be vaccinated against 
measles than their peers. One German study, using 
data from the representative German Health 
Interview and Examination Survey for children and 
Adolescents, found that children who were foreign-
born had a 3-fold higher risk of being unvaccinated 
[31,32]. Another analysis of the same data found that 
among vaccinated children, migrant status was asso-
ciated with being more susceptible to measles [33]. 
An Italian study reports that children born outside of 
Italy, or whose parents were born outside Italy, had 
lower immunization rates than native children 
(89.6% versus 87.3%, respectively), although it was 
not stated if this difference was statistically signifi-
cant [34]. A Spanish study found a statistically sig-
nificant difference in immunization rates between 
indigenous and immigrant children, for both primary 
coverage (96.5% and 85% coverage, respectively) 
and the primary vaccination plus booster dose 
(88.6% and 78.3%, respectively) [35].
Other studies in Spain also report that immigrant 
children have lower vaccination rates [36]. The 
authors point to the need for better vaccination cov-
erage, including among adults and those seeking 
work or visiting, whom may not come into contact 
with the health system [29,35,36]. One belgian study 
that defines migrant status as having one or more 
parents or grandparents born abroad, rather than the 
country of birth of a case, found that there were lower 
coverage rates in both adolescents with a non-Euro-
pean background and in primary schoolchildren with 
a European, but non-belgian background [37].
A major factor in the failure to achieve compara-
ble immunization rates among migrant populations 
is their poor access to health services. barriers to 
accessing health services include: cultural and lin-
guistic barriers, socioeconomic exclusion and dis-
crimination [20,38]. In many countries, ethnic 
minority children and children in socioeconomically 
disadvantaged families (both of which might include 
migrants) are less likely to be immunized [29]. 
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Having parents who do not speak the local language 
is another risk factor for low vaccination coverage 
among children [39,40].
A meeting of experts
A number of reasons for measles outbreaks in Eu/
EEA member states were presented at the infectious 
disease and migration expert meeting. Outbreaks 
were generally linked to low vaccination coverage in 
roma communities or particular religious groups, 
such as Orthodox Jews, and were infrequently linked 
with migrants.
reasons for measles outbreaks vary between coun-
tries, but they do not often correlate to migration. 
These can include:
 • Anthroposophic objectors (Steiner groups) 
(Germany)
 • religious groups (Netherlands)
 • low vaccination coverage, possibly unvaccinated 
migrant groups (France)
 • Autism scare (uk)
 • roma minorities (romania, bulgaria and balkan 
states)
 • Death after vaccination that was unrelated to vac-
cine: vaccination hype (ukraine)
 • Decentralized surveillance (Switzerland)
 • low political support (Austria)
 • Orthodox Jewish communities (belgium)
 • Anti-vaccination movements and low support 
among medical personnel (Eu-wide)
Survey of EU/EEA member states
Of the 30 countries surveyed, 22 returned the ques-
tionnaire on measles and rubella. There were 13 
countries that reported that they had collected infor-
mation on the migrant status of measles cases, using 
the criterion of ‘country of birth’. Only Greece and 
Spain reported that tourists or visitors were excluded 
from their ‘migrant’ category.
Within the 13 countries that collected information 
on the migrant status of measles cases, 72 of 909 
(7.92%) reported measles cases in 2010 were in 
migrants. by comparison, the total foreign-born pop-
ulation in these 13 countries in 2010 was 9.8%, as 
shown in Table I [41] .
Overall, in the period 2007–2010, 142 out of 
1995 (7.12%) measles cases in these countries 
occurred among migrants (Figure 1). There was 
wide variation between countries, with no cases 
reported in migrants in Slovenia, Malta, Hungary, 
Finland and Estonia, but 25.5% of cases reported in 
migrants in Greece and 75.9% of cases reported in 
migrants in Norway. Out of 13 countries, only three 
(Greece, the Netherlands and Norway) reported the 
vaccination status of measles cases in their responses 
to the survey, with only the Netherlands and Norway 
reporting vaccination coverage for migrants. In the 
Netherlands, none of the 28 measles cases reported 
in migrants from 2007–2010 had been vaccinated. 
In Norway, vaccination coverage was marginally 
higher, with two out of 22 measles cases (9%) in 
Table I. Foreign-born population in surveyed countries, 2010.
Native-born (%) Foreign-born (%)
Slovenia 87.6% 12.4%
Malta 93.6% 6.4%
Hungary 95.6% 4.4%
Finland 95.7% 4.3%
Estonia 83.7% 16.3%
Ireland 87.3% 12.7%
Spain 86.0% 14.0%
belgium – –
Netherlands 88.9% 11.1%
czech republic 96.2% 3.8%
Greece 88.9% 11.1%
Denmark 91.0% 9.0%
Norway 89.2% 10.8%
Source: Eurostat (2011).
Figure 1. Migrant status of measles cases in 2007–2010, using the 
country of birth variable.a
Source: Author’s survey of Eu member states.
a reporting on measles was based on mandatory notification sys-
tems, with case-based data.
In belgium, measles only became a notifiable infectious disease 
in 2010.
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migrants from 2007–2010 being reported as having 
been vaccinated.
When asked whether data for migrants were sub-
ject to any significant biases and/or inadequacies (e.g. 
incompleteness of data or inaccuracy of diagnoses), 
respondents from three countries (czech republic, 
Denmark and Spain) reported that there were no 
biases. In belgium, the data on measles were limited 
to the Flemish community. Incompleteness of data 
was also noted by other national focal points. In 
Ireland, it was reported that information on the coun-
try of birth was only available for 18% of those with 
measles cases in 2007–2010. Potential data incom-
pleteness as a result of migrants not seeking health 
care was mentioned by key informants in Greece, 
Malta and Slovenia. Finally, incompleteness of infor-
mation on the vaccination status of migrants was 
mentioned by the respondents from the Netherlands 
and Norway.
Limitations
This study inevitably has some limitations. We 
included only papers published in English, which 
may have limited the number of studies included 
from Eu/EEA member states that do not routinely 
publish in English. It should also be noted that the 
opinions provided for some questions in the country 
survey and at the lisbon meeting may be subject to 
biases, as they reflect the views of a limited number 
of measles experts.
Discussion
There is little information available on the occurrence 
of measles among migrants in Europe. Although 
national surveillance systems for measles are in place 
and regular reporting occurs, surveillance is incom-
plete in relation to migrant health. As noted, routine 
national surveillance data, as reported to the EcDc, 
do not record migrant-specific information such as 
country of birth, but rather record the importation 
status of cases, which are classified as ‘imported’, 
‘endemic’, ‘import-related’ or as being of ‘unknown’ 
origin. This variable is not an optimal proxy for migra-
tion, but rather indicates travelling in the days before 
disease onset. Our literature review identified few 
studies that assessed measles among the migrant pop-
ulations, with the literature instead focused on spe-
cific minorities at risk of measles, such as the roma, 
Traveller, anthroposophic and ultra-orthodox Jewish 
communities.
Despite these limitations, this study revealed 
important findings in relation to measles in migrant 
populations. Several studies did conclude that some 
measles outbreaks were linked to sub-optimal vaccina-
tion coverage in migrant populations, with migrant 
children being less likely to be vaccinated than their 
native counterparts [28,31,36,42]. Furthermore, a 
number of respondents to the member state survey 
noted that the potential data incompleteness on mea-
sles cases and the vaccination status as a result of 
migrants not seeking health care was an issue of con-
cern. The limited access of undocumented migrants to 
health care services is another area of concern that is 
emerging from the literature [43,44].
The survey of member states provided important 
additional information on measles in migrant popula-
tions, with 13 countries reporting information based 
on the ‘country of birth’ variable. In these 13 coun-
tries, migrants accounted for 7.1% of the measles 
cases in 2007–2010; however, there are widespread 
differences in reporting between countries, with 
some, such as Slovenia, Malta, Hungary, Finland and 
Estonia reporting no cases in migrants in 2010, but 
Greece and Norway 25.5% and 75.9% of their cases 
being in migrants, respectively.
The varying patterns of measles in migrant popu-
lations in different countries makes it essential that, 
even if measles is not a particular problem in their 
migrant communities now, all countries undertake 
routine surveillance of migrant-specific variables for 
measles cases to ensure that policy responses can be 
tailored to emerging developments in individual 
member states. In particular, surveillance systems 
should be strengthened to routinely capture 
migrant-specific variables for measles cases and for 
MMr vaccination rates. These data can help inform 
the provision of preventive services, which may need 
to reach out to vulnerable migrant populations that 
currently face barriers in accessing routine immuni-
zation and health services [27,45]; however, it will 
be important to think carefully about how to do 
this, to ensure that the rationale for doing so and the 
methods used are accepted by migrant communi-
ties, some of whom may be concerned about inter-
actions with statutory authorities. This may be 
mitigated by recruitment of community and health 
workers from migrant groups [46], and by policies 
that take advantage of research from other areas of 
health policy that highlight the need to take full 
account of the legal and cultural issues pertaining 
to each country, including the entitlement to 
health care and the levels of racism and xenopho-
bia [47,48].
Finally, it is important to note that these figures do 
not support the view that migrants overall have a 
higher burden of measles, contrary to perceptions 
that are widespread in some quarters. Indeed, a 
greater challenge in achieving measles elimination 
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may well be the indigenous communities, who, for 
whatever reason, have longstanding objections to the 
concept of immunization [49,50].
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